U.S. Pharmaceutical Sales - Q3 2011
The following is a list of the top 100 prescribed medicines by U.S. National Sales in Q3 2011. Figures include sales through both retail and hospital channels, listed by drug name and sales value in U.S. dollars.
Last updated: February 2014 (updated quarterly).
Top 100 drugs for Q3 2011 by sales
- Sales Statistics Q3 2011
- Units*
Rank |
Drug |
Sales ($000) |
|
|
1 |
Lipitor
|
1,969,877 |
1.05% |
Stats |
2 |
Plavix
|
1,630,951 |
-3.97% |
Stats |
3 |
Nexium AstraZeneca |
1,441,825 |
-5.64% |
Stats |
4 |
Abilify Otsuka Pharmaceutical Co., Ltd |
1,249,763 |
-1.34% |
Stats |
5 |
Singulair Merck |
1,110,538 |
-4.34% |
Stats |
6 ( 1) |
Seroquel AstraZeneca |
1,105,210 |
-2.15% |
Stats |
7 ( 1) |
Advair Diskus GlaxoSmithKline |
1,061,099 |
-7.01% |
Stats |
8 |
Crestor AstraZeneca |
1,053,383 |
-1.78% |
Stats |
9 ( 3) |
Cymbalta
|
913,796 |
6.08% |
Stats |
10 |
Remicade Janssen Pharmaceuticals, Inc. |
879,054 |
1.52% |
Stats |
11 ( 3) |
Humira AbbVie Inc. |
877,641 |
3.95% |
Stats |
12 ( 1) |
Enbrel Amgen Inc. |
858,997 |
1.27% |
Stats |
13 ( 2) |
Zyprexa
|
828,973 |
-4.04% |
Stats |
14 ( 1) |
Neulasta Amgen Inc. |
786,464 |
-3.86% |
Stats |
15 ( 6) |
Actos Takeda Pharmaceutical Company Limited |
779,504 |
-11.05% |
Stats |
16 |
Rituxan Genentech, Inc. |
721,408 |
-1.77% |
Stats |
17 ( 2) |
Copaxone Teva Pharmaceuticals USA, Inc. |
708,803 |
-1.66% |
Stats |
18 |
Lexapro Allergan plc |
696,883 |
-3.33% |
Stats |
19 ( 2) |
OxyContin Purdue Pharma LP |
687,676 |
-5.33% |
Stats |
20 ( 2) |
Atripla Gilead Sciences, Inc. |
627,084 |
0.42% |
Stats |
21 |
Avastin Genentech, Inc. |
626,618 |
-3.57% |
Stats |
22 ( 2) |
Epogen Amgen Inc. |
619,828 |
-13.96% |
Stats |
23 |
Spiriva Boehringer Ingelheim Pharmaceuticals, Inc. |
570,706 |
-1.46% |
Stats |
24 |
Januvia Merck |
515,840 |
1.19% |
Stats |
25 ( 2) |
Truvada Gilead Sciences, Inc. |
487,444 |
1.15% |
Stats |
26 |
Lantus Sanofi |
470,948 |
-3.61% |
Stats |
27 ( 2) |
Diovan Novartis Pharmaceuticals Corporation |
450,115 |
-9.44% |
Stats |
28 ( 2) |
Lucentis Genentech, Inc. |
429,393 |
1.13% |
Stats |
29 |
Lyrica
|
426,822 |
-2.94% |
Stats |
30 ( 2) |
Celebrex
|
421,670 |
-4.82% |
Stats |
31 ( 1) |
Herceptin Genentech, Inc. |
395,804 |
-0.64% |
Stats |
32 ( 1) |
Diovan HCT Novartis Pharmaceuticals Corporation |
387,064 |
-8.54% |
Stats |
33 |
Avonex Biogen |
379,457 |
-0.05% |
Stats |
34 ( 2) |
Lantus Solostar Sanofi |
376,208 |
4.53% |
Stats |
35 ( 2) |
Gleevec Novartis Pharmaceuticals Corporation |
374,171 |
5.88% |
Stats |
36 ( 2) |
Namenda Allergan plc |
359,537 |
-2.67% |
Stats |
37 ( 2) |
OneTouch
|
359,152 |
-2.46% |
Stats |
38 ( 1) |
enoxaparin Generic |
354,293 |
5.21% |
Stats |
39 ( 16) |
Eloxatin Sanofi |
353,940 |
34.41% |
Stats |
40 ( ) |
Incivek Vertex Pharmaceuticals Incorporated |
335,582 |
n/a |
Stats |
41 ( 2) |
Geodon
|
334,275 |
3.81% |
Stats |
42 |
TriCor AbbVie Inc. |
321,079 |
-0.32% |
Stats |
43 ( 4) |
Suboxone
|
311,941 |
6.42% |
Stats |
44 ( 4) |
Zetia Merck |
311,388 |
-7.20% |
Stats |
45 ( 1) |
Vyvanse Takeda Pharmaceutical Company Limited |
308,386 |
1.08% |
Stats |
46 |
Lidoderm Endo Pharmaceuticals Inc. |
288,696 |
-2.41% |
Stats |
47 ( 3) |
Provigil
|
285,873 |
3.92% |
Stats |
48 ( 29) |
Varivax Merck |
276,857 |
42.23% |
Stats |
49 ( 4) |
Niaspan AbbVie Inc. |
267,018 |
-11.86% |
Stats |
50 ( 1) |
AndroGel AbbVie Inc. |
265,966 |
-5.89% |
Stats |
51 ( 3) |
Aranesp Amgen Inc. |
261,967 |
-10.25% |
Stats |
52 ( 31) |
methylphenidate Generic |
260,992 |
41.59% |
Stats |
53 ( 12) |
Procrit Janssen Pharmaceuticals, Inc. |
260,610 |
-21.61% |
Stats |
54 ( 5) |
Rebif EMD Serono, Inc. |
257,535 |
1.48% |
Stats |
55 ( 10) |
Seroquel XR AstraZeneca |
256,141 |
2.65% |
Stats |
56 ( 1) |
Combivent Boehringer Ingelheim Pharmaceuticals, Inc. |
255,615 |
-0.53% |
Stats |
57 ( 9) |
amphetamine/dextroamphetamine Generic |
255,231 |
3.47% |
Stats |
58 ( 5) |
Alimta Eli Lilly and Company |
255,178 |
1.37% |
Stats |
59 ( 5) |
Viagra
|
253,141 |
1.29% |
Stats |
60 ( 1) |
Novolog Novo Nordisk |
249,591 |
-0.96% |
Stats |
61 ( 7) |
Vytorin Merck |
244,078 |
-8.10% |
Stats |
62 ( 9) |
Lovenox Sanofi |
243,627 |
-8.33% |
Stats |
63 ( 4) |
Humalog Eli Lilly and Company |
242,208 |
-0.75% |
Stats |
64 ( 4) |
Symbicort AstraZeneca |
240,761 |
-4.65% |
Stats |
65 ( 5) |
Neupogen Amgen Inc. |
237,915 |
0.69% |
Stats |
66 ( 8) |
ProAir HFA Teva Pharmaceuticals USA, Inc. |
236,487 |
9.84% |
Stats |
67 ( 9) |
Lovaza GlaxoSmithKline |
231,896 |
-8.96% |
Stats |
68 ( 17) |
Nasonex Merck |
230,174 |
-14.77% |
Stats |
69 ( 1) |
metoprolol Generic |
229,868 |
-4.57% |
Stats |
70 ( 1) |
Reyataz Bristol-Myers Squibb Company |
226,939 |
-2.22% |
Stats |
71 ( 9) |
Adderall XR Takeda Pharmaceutical Company Limited |
219,669 |
-12.77% |
Stats |
72 ( 3) |
Flovent HFA GlaxoSmithKline |
213,037 |
-10.26% |
Stats |
73 ( 17) |
Solodyn Medicis Pharmaceutical Corporation |
211,536 |
18.36% |
Stats |
74 ( 1) |
fentanyl Generic |
210,250 |
-2.89% |
Stats |
75 ( 3) |
Aciphex Eisai Inc. |
209,632 |
-6.32% |
Stats |
76 ( 1) |
Levemir Novo Nordisk |
201,824 |
1.83% |
Stats |
77 ( ) |
Prevnar 13 Pfizer Inc. |
194,677 |
n/a |
Stats |
78 ( 6) |
Isentress Merck |
194,642 |
6.05% |
Stats |
79 ( 1) |
Cialis Eli Lilly and Company |
192,331 |
1.03% |
Stats |
80 ( 6) |
NovoLog FlexPen Novo Nordisk |
189,267 |
4.15% |
Stats |
81 ( 5) |
Lunesta Sunovion Pharmaceuticals Inc. |
188,531 |
-3.44% |
Stats |
82 ( 4) |
Janumet Merck |
188,050 |
-2.60% |
Stats |
83 ( 1) |
docetaxel Generic |
179,876 |
-2.92% |
Stats |
84 ( 3) |
Evista
|
176,642 |
-2.26% |
Stats |
85 ( 10) |
budesonide Generic |
175,543 |
5.36% |
Stats |
86 ( 2) |
Restasis Allergan plc |
175,330 |
-2.15% |
Stats |
87 ( 2) |
Betaseron Bayer HealthCare Pharmaceuticals Inc. |
173,769 |
-2.89% |
Stats |
88 ( 3) |
Zyvox Pfizer Inc. |
170,871 |
-3.78% |
Stats |
89 ( 5) |
Velcade Takeda Pharmaceutical Company Limited |
170,665 |
2.42% |
Stats |
90 ( 3) |
Erbitux Eli Lilly and Company |
167,909 |
-2.48% |
Stats |
91 ( ) |
Xeloda Genentech, Inc. |
165,875 |
n/a |
Stats |
92 ( ) |
Pradaxa Boehringer Ingelheim Pharmaceuticals, Inc. |
164,496 |
n/a |
Stats |
93 ( 1) |
Benicar Daiichi Sankyo |
161,995 |
-5.94% |
Stats |
94 ( ) |
Opana ER Endo Pharmaceuticals Inc. |
161,602 |
n/a |
Stats |
95 ( 4) |
Synthroid AbbVie Inc. |
160,078 |
-0.04% |
Stats |
96 ( 2) |
acetaminophen/hydrocodone Generic |
159,532 |
-0.90% |
Stats |
97 ( 1) |
Zometa Novartis Pharmaceuticals Corporation |
159,059 |
-4.27% |
Stats |
98 ( ) |
Fluvirin Seqirus |
158,294 |
n/a |
Stats |
99 ( 2) |
VESIcare Astellas Pharma US, Inc. |
157,269 |
-2.74% |
Stats |
100 ( ) |
Prezista Janssen Pharmaceuticals, Inc. |
155,442 |
n/a |
Stats |
* Units refer to the number of packages sold.
Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.